Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin

American Journal of Pathology

Volumn 184, Issue 5, 2014, Pages 1617-1628

  Xia, Min ^a   Boini, Krishna M ^a   Abais, Justine M ^a   Xu, Ming ^a   Zhang, Yang ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NUCLEOTIDE OLIGOMERIZATION DOMAIN LIKE RECEPTOR PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG; ADIPOCYTOKINE; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CASPASE INHIBITOR; CIAS1 PROTEIN, MOUSE; PYCARD PROTEIN, MOUSE; SMALL INTERFERING RNA; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY LIGATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; GENE EXPRESSION; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEOINTIMA; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CAROTID ARTERY; DRUG EFFECTS; ENDOTHELIUM CELL; GENE SILENCING; LIGATION; METABOLISM; MICROVASCULATURE; MOUSE MUTANT; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION; SIZE EXCLUSION CHROMATOGRAPHY;

ADIPOKINES; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CAROTID ARTERIES; CARRIER PROTEINS; CASPASE 1; CASPASE INHIBITORS; CHROMATOGRAPHY, GEL; ENDOTHELIAL CELLS; GENE SILENCING; INFLAMMASOMES; INTERLEUKIN-1BETA; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROVESSELS; NEOINTIMA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATION-REDUCTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84899564349     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.01.032     Document Type: Article

References (52)

1. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
2. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nunez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, and E. Latz NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
3. S.L. Masters, E. Latz, and L.A. O'Neill The inflammasome in atherosclerosis and type 2 diabetes Sci Transl Med 3 2011 81ps17
4. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
5. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
6. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
7. H. Wen, J.P. Ting, and L.A. O'Neill A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation? Nat Immunol 13 2012 352 357
8. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell Inflammasomes in health and disease Nature 481 2012 278 286
9. F. Martinon, A. Mayor, and J. Tschopp The inflammasomes: guardians of the body Annu Rev Immunol 27 2009 229 265
10. N. Busso, and A. So Mechanisms of inflammation in gout Arthritis Res Ther 12 2010 206
11. R. Stienstra, C.J. Tack, T.D. Kanneganti, L.A. Joosten, and M.G. Netea The inflammasome puts obesity in the danger zone Cell Metab 15 2012 10 18
12. S. Mariathasan, K. Newton, D.M. Monack, D. Vucic, D.M. French, W.P. Lee, M. Roose-Girma, S. Erickson, and V.M. Dixit Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf Nature 430 2004 213 218
13. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
14. A. Halle, V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, T. Reinheckel, K.A. Fitzgerald, E. Latz, K.J. Moore, and D.T. Golenbock The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat Immunol 9 2008 857 865
15. Y. Zheng, S.E. Gardner, and M.C. Clarke Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease Arterioscler Thromb Vasc Biol 31 2011 2781 2786
16. C.A. Dinarello, M.Y. Donath, and T. Mandrup-Poulsen Role of IL-1beta in type 2 diabetes Curr Opin Endocrinol Diabetes Obes 17 2010 314 321
17. G. Rodriguez, N. Mago, and F. Rosa [Role of inflammation in atherogenesis]. Spanish Invest Clin 50 2009 109 129
18. V.A. Rathinam, S.K. Vanaja, and K.A. Fitzgerald Regulation of inflammasome signaling Nat Immunol 13 2012 333 342
19. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, M.T. Huang, W.J. Brickey, and J.P. Ting Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat Immunol 12 2011 408 415
20. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 1994 1431 1437
21. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, K. Kishimoto, Y. Matsuki, M. Murakami, T. Ichisaka, H. Murakami, E. Watanabe, T. Takagi, M. Akiyoshi, T. Ohtsubo, S. Kihara, S. Yamashita, M. Makishima, T. Funahashi, S. Yamanaka, R. Hiramatsu, Y. Matsuzawa, and I. Shimomura Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430
22. E. Adeghate Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions Curr Med Chem 15 2008 1851 1862
23. T.B. Dahl, A. Yndestad, M. Skjelland, E. Oie, A. Dahl, A. Michelsen, J.K. Damas, S.H. Tunheim, T. Ueland, C. Smith, B. Bendz, S. Tonstad, L. Gullestad, S.S. Froland, K. Krohg-Sorensen, D. Russell, P. Aukrust, and B. Halvorsen Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 2007 972 980
24. M. Zhong, H.W. Tan, H.P. Gong, S.F. Wang, Y. Zhang, and W. Zhang Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis Clin Endocrinol (Oxf) 69 2008 878 884
25. M.I. Yilmaz, M. Saglam, J.J. Carrero, A.R. Qureshi, K. Caglar, T. Eyileten, A. Sonmez, E. Cakir, M. Yenicesu, B. Lindholm, P. Stenvinkel, and J. Axelsson Serum visfatin concentration and endothelial dysfunction in chronic kidney disease Nephrol Dial Transplant 23 2008 959 965
26. S.G. Spiroglou, C.G. Kostopoulos, J.N. Varakis, and H.H. Papadaki Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis J Atheroscler Thromb 17 2010 115 130
27. A.R. Moschen, A. Kaser, B. Enrich, B. Mosheimer, M. Theurl, H. Niederegger, and H. Tilg Visfatin, an adipocytokine with proinflammatory and immunomodulating properties J Immunol 178 2007 1748 1758
28. M. Xia, C. Zhang, K.M. Boini, A.M. Thacker, and P.L. Li Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin Cardiovasc Res 89 2011 401 409
29. K.M. Boini, C. Zhang, M. Xia, W.Q. Han, C. Brimson, J.L. Poklis, and P.L. Li Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells Biochim Biophys Acta 1801 2010 1294 1304
30. D. Nam, C.W. Ni, A. Rezvan, J. Suo, K. Budzyn, A. Llanos, D. Harrison, D. Giddens, and H. Jo Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis Am J Physiol Heart Circ Physiol 297 2009 H1535 H1543
31. H. Merino, S. Parthasarathy, and D.K. Singla Partial ligation-induced carotid artery occlusion induces leukocyte recruitment and lipid accumulation-a shear stress model of atherosclerosis Mol Cell Biochem 372 2013 267 273
32. K.M. Boini, C. Zhang, M. Xia, J.L. Poklis, and P.L. Li Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet J Pharmacol Exp Ther 334 2010 839 846
33. J. Chamberlain, D. Evans, A. King, R. Dewberry, S. Dower, D. Crossman, and S. Francis Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice Am J Pathol 168 2006 1396 1403
34. J. Chamberlain, J. Gunn, S. Francis, C. Holt, and D. Crossman Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries Cardiovasc Res 44 1999 156 165
35. M. Reimann, T. Ziemssen, H.W. Huisman, R. Schutte, L. Malan, J.M. Van Rooyen, R.H. Boger, N.T. Malan, and A.E. Schutte Ethnic-specific correlations of visfatin with circulating markers of endothelial inflammation and function Obesity (Silver Spring) 17 2009 2210 2215
36. N. Mizushima, B. Levine, A.M. Cuervo, and D.J. Klionsky Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075
37. B.S. Park, S.H. Jin, J.J. Park, J.W. Park, I.S. Namgoong, Y.I. Kim, B.J. Lee, and J.G. Kim Visfatin induces sickness responses in the brain PLoS One 6 2011 e15981
38. D.P. Abulafia, J.P. de Rivero Vaccari, J.D. Lozano, G. Lotocki, R.W. Keane, and W.D. Duetruch Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice J Cereb Blood Flow Metab 29 2009 534 544
39. M. Xiang, X. Shi, Y. Li, J. Xu, L. Yin, G. Xiao, M.J. Scott, T.R. Billiar, M.A. Wilson, and J. Fan Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells J Immunol 187 2011 4809 4817
40. A.B. Imaeda, A. Watanabe, M.A. Sohail, S. Mahmood, M. Mohamadnejad, F.S. Sutterwala, R.A. Flavell, and W.Z. Mehal Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J Clin Invest 119 2009 305 314
41. Y. Yin, Y. Yan, X. Jiang, J. Mai, N.C. Chen, H. Wang, and X.F. Yang Inflammasomes are differentially expressed in cardiovascular and other tissues Int J Immunopathol Pharmacol 22 2009 311 322
42. A.S. Yazdi, S.K. Drexler, and J. Tschopp The role of the inflammasome in nonmyeloid cells J Clin Immunol 30 2010 623 627
43. C.M. Cruz, A. Rinna, H.J. Forman, A.L. Ventura, P.M. Persechini, and D.M. Ojcius ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages J Biol Chem 282 2007 2871 2879
44. C. Dostert, V. Petrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 320 2008 674 677
45. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10 2010 210 215
46. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp Thioredoxin-interacting protein links oxidative stress to inflammasome activation Nat Immunol 11 2010 136 140
47. F. Yi, M. Xia, N. Li, C. Zhang, L. Tang, and P.L. Li Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats Hypertension 53 2009 90 96
48. R. Bekeredjian, S. Chen, P.A. Frenkel, P.A. Grayburn, and R.V. Shohet Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart Circulation 108 2003 1022 1026
49. S. Chen, R.V. Shohet, R. Bekeredjian, P. Frenkel, and P.A. Grayburn Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction J Am Coll Cardiol 42 2003 301 308
50. S. Tsunoda, O. Mazda, Y. Oda, Y. Iida, S. Akabame, T. Kishida, M. Shin-Ya, H. Asada, S. Gojo, J. Imanishi, H. Matsubara, and T. Yoshikawa Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart Biochem Biophys Res Commun 336 2005 118 127
51. S. Ognjanovic, S. Bao, S.Y. Yamamoto, J. Garibay-Tupas, B. Samal, and G.D. Bryant-Greenwood Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes J Mol Endocrinol 26 2001 107 117
52. M. Gosset, F. Berenbaum, C. Salvat, A. Sautet, A. Pigenet, K. Tahiri, and C. Jacques Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis Arthritis Rheum 58 2008 1399 1409